Oxford Immunotec
Oxford Immunotec develops T-SPOT ELISPOT-based diagnostic tests for T cell immune response measurement, serving clinical laboratories, pharmaceutical and biotech firms, healthcare professionals, academic researchers, and CROs across 40+ countries via Revvity's global distribution network.
- Company typePrivate
- Founded2000
- HeadquartersAbingdon, United Kingdom
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Oxford Immunotec does
Oxford Immunotec is a medical diagnostics company that built its business around the proprietary T-SPOT Technology, an ELISPOT-based platform for measuring T cell immune responses via interferon-gamma release assay (IGRA) methodology. The company's core product, the T-SPOT.TB test (TB.300), detects latent tuberculosis infection with a standardized three-step workflow of cell isolation, washing, and counting that produces reportable results independent of patient cell counts; the adjacent T-SPOT.Flex kit supports research-use T cell monitoring, while the T-Cell Select kit (TSK.910) enables T cell isolation, and the Auto-Pure 10B instrument automates sample processing. The company also operates Oxford Diagnostic Laboratories (ODL), a high-throughput reference lab in Abingdon, UK that processes more than 400 TB samples per day, and has extended the platform into cytomegalovirus (CMV) testing for immunocompromised transplant patients.
The company was founded in 2002 in Abingdon, UK, listed on NASDAQ under OXFD, and was acquired by PerkinElmer in 2022 for approximately $591 million. PerkinElmer subsequently rebranded as Revvity, Inc. in 2023, and the T-SPOT portfolio now operates within Revvity's diagnostics and clinical services divisions, distributed across 40+ countries via direct enterprise sales, regional e-commerce portals, and authorized distributors. Its customer base spans clinical laboratories, pharmaceutical/biotech companies conducting immune monitoring and vaccine research, healthcare professionals managing transplant patients, academic researchers, and contract research organizations, with revenue generated from consumable kit sales, capital instrument placements, and reference laboratory testing services.
Since the Oxford Immunotec brand no longer trades independently, T-SPOT.TB and related products are positioned as one line within Revvity's larger diagnostics franchise, with pricing handled through a quote-based enterprise sales motion and digital promotional channels layered on top via Revvity's e-commerce platform.
Oxford Immunotec firmographics
Firmographics- Name
- Oxford Immunotec
- Legal name
- Oxford Immunotec Global, Ltd.
- Website
- https://oxfordimmunotec.com
- Company type
- Private
- Founded year
- 2000
- Operating status
- Acquired
- Headcount range
- 101–250 employees
- Short description
- Oxford Immunotec develops T-SPOT ELISPOT-based diagnostic tests for T cell immune response measurement, serving clinical laboratories, pharmaceutical and biotech firms, healthcare professionals, academic researchers, and CROs across 40+ countries via Revvity's global distribution network.
- Ownership category
- akta.pro rank
Oxford Immunotec industry classification
Industry- Product category
- Infectious Disease Diagnostics
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Medical Laboratories (621511)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Immunoassay Diagnostics (ELISA, chemiluminescence, serology) (HLAAALAB)
- akta.pro secondary industry
- Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB)
Keywords
Where Oxford Immunotec is headquartered
LocationHeadquarters
- HQ city
- Abingdon
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
Oxford Immunotec business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Technology or R&D, Operations, Marketing or Sales
Revenue model
- T-SPOT Diagnostic Products: Sale of T-SPOT assay kits including T-SPOT.TB (TB.300), T-SPOT.Flex (FLEX.24.RUO), and T-Cell Select (TSK.910) for clinical and research applications. Revenue generated from kit sales to clinical laboratories, hospitals, and research institutions.
- Instrument Sales: Sale of instruments including Auto-Pure 10B for automated sample processing. Hardware instruments are sold as capital equipment purchases or potentially with service agreements.
- Testing Services (Oxford Diagnostic Laboratories): Oxford Diagnostic Laboratories (ODL) operates as a referral laboratory providing TB testing services using T-SPOT technology. The lab receives over 400 samples per day for TB testing, generating revenue from diagnostic testing services.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Quote-based pricing for all products |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels5 records
Oxford Immunotec product offering
Product offeringCore offering
Oxford Immunotec develops and sells diagnostic test kits, instruments, and reagents based on its proprietary T-SPOT Technology, an ELISPOT (Enzyme-Linked ImmunoSpot) platform that measures T cell immune responses using interferon-gamma release assay (IGRA) methodology. Its core commercial product is the T-SPOT.TB test for tuberculosis detection, supplemented by T-SPOT.Flex research kits, T-Cell Select cell isolation kits, and the Auto-Pure 10B automated instrument. The company also operates Oxford Diagnostic Laboratories (ODL), a UK reference laboratory providing centralized TB testing services processing over 400 samples per day.
Product overview
Oxford Immunotec's T-SPOT portfolio, now part of Revvity following acquisition, consists of a unified platform-plus-products architecture centered on ELISPOT technology for T cell immune response measurement. The core T-SPOT Technology platform provides the foundational IGRA methodology for detecting cell-mediated immunity. This platform supports diagnostic test products including T-SPOT.TB (TB.300) for tuberculosis detection, T-SPOT.Flex (FLEX.24.RUO) for research applications, and T-Cell Select (TSK.910) for cell isolation. Workflow automation is enabled through the Auto-Pure 10B instrument for automated sample processing. Clinical testing services are provided through Oxford Diagnostic Laboratories (ODL). The product ecosystem spans from cell isolation through automated analysis, with the T-SPOT technology serving as the common methodological foundation across all offerings.
Differentiator
Problem solved
Functional benefit
Brands
- T-SPOT Technology: ELISPOT-based platform for measuring T cell immune responses, including the T-SPOT.TB test for tuberculosis detection and T-SPOT.Flex for research applications.
- Oxford Diagnostic Laboratories (ODL)
Products and services
- T-SPOT.TB (TB.300)
Quantifiable outcome
- 400+ samples per day processed through Oxford Diagnostic Laboratories
- +1 more outcomes
Companies that use Oxford Immunotec
Customer profileNamed customers1 record
Segments5 records
Ideal customer profiles5 records
Oxford Immunotec technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Oxford Immunotec partnerships and signals
Strategic signalScale indicators4 records
Recent moves6 records
Expansion highlights5 records
Oxford Immunotec competitors and assessment
Company assessmentBroad incumbents
- Abbott: Abbott is a major IVD incumbent with ARCHITECT and other immunoassay platforms serving clinical labs worldwide, providing competing TB and infectious disease diagnostic solutions for the same hospital and reference lab customers.
- Thermo Fisher Scientific: Thermo Fisher is a global diagnostics and life sciences incumbent offering immunoassays, clinical lab services, and research reagents, serving the same clinical lab and pharma/biotech customers as Oxford Immunotec's T-SPOT portfolio.
- Bio-Techne: Bio-Techne is a large life sciences tools incumbent offering immunoassay kits, ELISpot reagents, and cytokines under the R&D Systems and Tocris brands, with overlapping research customer bases to Oxford Immunotec's T-SPOT.Flex.
- Roche Diagnostics: Roche Diagnostics is a global IVD incumbent serving clinical laboratories with a broad infectious disease and immunoassay portfolio, including TB testing solutions competing with T-SPOT.TB in large hospital networks.
- Hologic: Hologic is a diagnostics-focused incumbent offering molecular and immunoassay platforms for infectious disease, including TB testing capabilities that overlap with Oxford Immunotec's clinical laboratory customer segments.
- Becton Dickinson (BD): BD is a major diagnostics and life sciences incumbent with flow cytometry and immunology assay platforms serving clinical labs and research institutions, overlapping with Oxford Immunotec's T cell measurement focus.
Emerging players
- DiaSorin: DiaSorin offers the LIAISON QuantiFERON-TB test and other specialty IVD assays, providing a competing TB IGRA solution to clinical laboratories, though with a broader infectious disease and specialty diagnostics portfolio than Oxford Immunotec.
Direct peers
- Qiagen: Qiagen's QuantiFERON-TB Gold Plus is the leading IGRA test for latent TB detection and the primary direct competitor to Oxford Immunotec's T-SPOT.TB in clinical laboratories and TB screening programs globally.
- Cellular Technology Limited (CTL): CTL is a named dominant player in the ELISpot market alongside Oxford Immunotec and Mabtech, providing competing T cell measurement platforms and instruments for immunology research.
- Mabtech: Mabtech is a named dominant player in the ELISpot/FluoroSpot assay market alongside Oxford Immunotec, offering competing T cell immunoassay kits and reagents for research and clinical applications.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
Oxford Immunotec social profiles
Digital presenceOxford Immunotec financial estimates
Financial estimateRevenue estimate
Valuation estimate
Oxford Immunotec leadership team
Management profileNumber of profiles
Oxford Immunotec subsidiaries and ownership
Company hierarchySubsidiaries1 record
Oxford Immunotec funding detail
Funding detailFunding overview
Funding rounds8 records
Investors15 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Oxford Immunotec M&A and investment
M&A and investmentM&A3 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Oxford Immunotec
What does Oxford Immunotec do?
Oxford Immunotec develops and sells diagnostic test kits, instruments, and reagents based on its proprietary T-SPOT Technology, an ELISPOT (Enzyme-Linked ImmunoSpot) platform that measures T cell immune responses using interferon-gamma release assay (IGRA) methodology. Its core commercial product is the T-SPOT.TB test for tuberculosis detection, supplemented by T-SPOT.Flex research kits, T-Cell Select cell isolation kits, and the Auto-Pure 10B automated instrument. The company also operates Oxford Diagnostic Laboratories (ODL), a UK reference laboratory providing centralized TB testing services processing over 400 samples per day.
Is Oxford Immunotec a public or private company?
Oxford Immunotec is a private company. It is classified as corporate owned and is currently acquired.
When was Oxford Immunotec founded?
Oxford Immunotec was founded in 2000. It employs 101 to 250 people.
Where is Oxford Immunotec based?
Oxford Immunotec is headquartered in Abingdon, United Kingdom, in the Europe region.
How does Oxford Immunotec make money?
Three revenue lines are on record. T-SPOT Diagnostic Products are the primary driver. The others are instrument Sales and testing Services (Oxford Diagnostic Laboratories).
Who are Oxford Immunotec's main competitors?
Broad incumbents on record are Abbott, Thermo Fisher Scientific, Bio-Techne, Roche Diagnostics, Hologic and Becton Dickinson (BD). DiaSorin is listed as an emerging player. Direct peers are Qiagen, Cellular Technology Limited (CTL) and Mabtech.
Does Oxford Immunotec have an API?
No public API is recorded for Oxford Immunotec.
What industry is Oxford Immunotec in?
Oxford Immunotec's product category is Infectious Disease Diagnostics. Its primary akta.pro industry code is HLAAALAB, Immunoassay Diagnostics (ELISA, chemiluminescence, serology), with a secondary code of HLAGAEAB, Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry). Its NAICS code is 325413 and its SIC code is 2835.